Skip to main content
. 2017 Dec 21;9(5):6238–6244. doi: 10.18632/oncotarget.23560

Table 3. Heparanase staining intensity and recurrent disease in breast carcinomas.

Heparanase staining intensity Number of patients (%) Recurrent disease (%)
Negative (0) 16 (13) 5 (31)
Weak (+1) 54 (45) 23 (42)
Strong (+2) 51 (42) 22 (43)